IN2013MU02059A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02059A
IN2013MU02059A IN2059MU2013A IN2013MU02059A IN 2013MU02059 A IN2013MU02059 A IN 2013MU02059A IN 2059MU2013 A IN2059MU2013 A IN 2059MU2013A IN 2013MU02059 A IN2013MU02059 A IN 2013MU02059A
Authority
IN
India
Prior art keywords
apixaban
relates
improved process
intermediates
preparation
Prior art date
Application number
Other languages
English (en)
Inventor
Shriprakash Dhar Dwivedi
Kumar Kamlesh Singh
Nitin Tandon
Digambar Ware
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Priority to US14/898,089 priority Critical patent/US20160113912A1/en
Priority to PCT/IN2014/000401 priority patent/WO2014203275A2/en
Priority to IN2059MU2013 priority patent/IN2013MU02059A/en
Publication of IN2013MU02059A publication Critical patent/IN2013MU02059A/en

Links

IN2059MU2013 2013-06-18 2014-06-17 IN2013MU02059A (xx)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US14/898,089 US20160113912A1 (en) 2013-06-18 2014-06-17 An improved process for the preparation of apixaban and intermediates thereof
PCT/IN2014/000401 WO2014203275A2 (en) 2013-06-18 2014-06-17 An improved process for the preparation of apixaban and intermediates thereof
IN2059MU2013 IN2013MU02059A (xx) 2013-06-18 2014-06-17

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2059MU2013 IN2013MU02059A (xx) 2013-06-18 2014-06-17

Publications (1)

Publication Number Publication Date
IN2013MU02059A true IN2013MU02059A (xx) 2015-08-07

Family

ID=54396356

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2059MU2013 IN2013MU02059A (xx) 2013-06-18 2014-06-17

Country Status (1)

Country Link
IN (1) IN2013MU02059A (xx)

Similar Documents

Publication Publication Date Title
WO2014203275A3 (en) An improved process for the preparation of apixaban and intermediates thereof
PH12015501609A1 (en) Phenicol antibacterials
PH12016500094A1 (en) Autotaxin inhibitors
MX2013001677A (es) Formulaciones estables de linaclotida.
IN2014DN09434A (xx)
UA109868C2 (xx) Сполуки n-алкілтриазолу як антагоністи лізофосфатидної кислоти (lpar)
GB201106743D0 (en) Novel compounds
PH12014501514A1 (en) New azetidine derivatives, pharmaceutical compositions and uses thereof
BR112015000229A2 (pt) formulações aquosas estáveis de etanercept
SG10201804817TA (en) Delayed release compositions of linaclotide
MX2019012939A (es) Formulaciones que contienen linaclotida para administracion oral.
MY157673A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
IN2013MU03583A (xx)
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
MX366829B (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
PH12015501377A1 (en) Solid unit with high fexofenadine content and process for the preparation thereof
MX2015010486A (es) Composicion masticable para administracion oral y proceso para preparar la misma.
MX2014014814A (es) Composicion farmaceutica para el tratamiento de inflamacion y dolor.
PH12015501251A1 (en) Compositions and methods for treating dental caries
MX2014014817A (es) Compuestos para el tratamiento de inflamacion y dolor.
IN2013CH04314A (xx)
IN2013MU03428A (xx)
EA201500446A1 (ru) Фармацевтическая композиция для снижения уровня n-оксида триметиламина
IN2013MU02059A (xx)
WO2014122671A3 (en) Solid oral compositions of saxagliptin